Open Medicine (Feb 2022)
Prognostic value of nicotinamide N-methyltransferase in human cancers: Evidence from a meta-analysis and database validation
Abstract
Previous studies indicated that dysregulated expression of nicotinamide N-methyltransferase (NNMT) contributed to the tumor progression and predicted poor prognosis in various cancers. However, there was no exact conclusion on account of the contradictory results across studies.
Keywords